New coating may reduce blood clot risk inside stents

Coating artery-opening stents with a new compound may someday eliminate a common side effect of the treatment, according to preliminary research in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology.

Stents are tiny mesh tubes that prop open so blood will flow freely to heart muscle, relieving chest pain and reducing the risk of heart attack. But implanting a stent damages the inner lining of the artery, triggering overgrowth of smooth muscle in the middle layer of the artery, a process that can re-narrow the passageway as the vessel wall thickens. To prevent this, stents are frequently coated with one of several medications that block smooth muscle growth.

However, the drugs that inhibit re-narrowing don't prevent another possible problem—blood clots forming inside the vessel with the stent—and make the side effect more likely. This happens because the medications also interfere with the repair and regrowth of a smooth and healthy layer of blood vessel lining cells (called endothelium) in the area of the stent.

In animal experiments of blood , researchers found that a compound called a CTP synthase inhibitor successfully blocked smooth muscle growth and either promoted or didn't interfere with the growth of .

"We hope it may someday provide a long-term fix by supporting repair of the injured endothelium," said Shi-You Chen, Ph.D., senior author of the study and associate professor of physiology in the Department of Physiology and Pharmacology at the University of Georgia College of Veterinary Medicine in Athens. "Most currently available drug-eluting stents also stop the growth of the inner layer of endothelial cells. This delays repair of the stent-injured lining and can trigger inflammation and formation of a blood clot at the injury site, which may severely block coronary and damage the heart."

Patients with stents are at the greatest risk for blood clots within the first 30 days after the initial procedure, but the potential for blood clots remains a year or more after stent insertion.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Extending the effective lifetime of stents

Oct 06, 2011

Implanted stents can reopen obstructed arteries, but regrowth of cells into the vessel wall can entail restenosis. Research at LMU now shows that an antimicrobial peptide inhibits restenosis and promotes vascular healing. ...

Zinc: The perfect material for bioabsorbable stents?

Apr 30, 2013

(Phys.org) —In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens ...

A new stent design may put patients at risk

Nov 17, 2011

Some stents that keep blood vessels open to treat heart disease are poorly designed to resist shortening, according to publications in the Journal of Interventional Cardiology. A case report published in the journal by Dr. ...

Recommended for you

ASHG: MI without substantial CAD is minimally heritable

8 hours ago

(HealthDay)—The presence of myocardial infarction (MI) without substantial coronary artery disease (CAD) is not familial, according to a study presented at the annual meeting of the American Society of ...

New treatment for inherited cholesterol

14 hours ago

At the London Olympics in 2012, South African swimmer Cameron van den Burgh dedicated his world record-breaking win in the 100m breast stroke to one of his biggest rivals and closest friends, Alexander Dale ...

Alternate approach to traditional CPR saves lives

20 hours ago

A new study shows that survival and neurological outcomes for patients in cardiac arrest can be improved by adding extracorporeal membrane oxygenation (ECMO) when performing cardiopulmonary resuscitation (CPR). The study ...

User comments